For nearly two decades it has been suspected that the cutaneous T cell lymphoma, mycosis fungoides (MF), and its leukemic variant, the Sezary syndrome, are caused by the human T lymphotropic virus (HTLV-I/ll). Arguments against this concept included the finding that only a small number of MF patients have antibodies to HTLV-I/ll and that attempts to detect proviral sequences by mere Southern hybridization of extracted DNA usually met with failure. However, we have reported repeatedly that HTLV-like particles emerge in blood mononuclear cell (PBMC) cultures of practically all patients with this disease. In several instances, the particles were identified as HTLV by immunoelectron microscopy as well as biomolecular analysis. With the assumptions that the virus in MF patients may have become defective and that the remaining signal may be too weak for detection by Southern hybridization alone, the extracts of freshly isolated PBMC of 50 consecutive patients were subjected to combined PCR/Southern analysis. Here we report the presence of HTLV pol and/or tax proviral sequences in 46 out of 50 (92%) of the patients tested. In addition, five of the patients, who lacked antibodies to HTLV-I/ll structural proteins, were found to be seropositive for tax. It thus seems reasonable to conclude that MF/ Sezary syndrome is an HTLV-associated disease and that lack of an immune response does not preclude infection with this type of virus. (J. Clin. Invest. 1995. 95:547-554.)
Introduction
The human T cell lymphotropic virus type I (HTLV-I)' is known to be the etiologic agent of adult T cell leukemia/ 1. Abbreviations used in this paper: ATLL, adult T cell leukemia/ lymphoma; CLL, chronic lymphocytic leukemia; HTLV-I/IH, human T cell lymphotropic virus types I and II; MF, mycosis fungoides; SS, Sezary syndrome. lymphoma (ATLL) (1) (2) (3) (4) and the neurological conditions tropical spastic paraparesis (5) and HTLV-associated myelopathy (6) . These relationships were demonstrated by the consistent detection of antibodies to HTLV virion proteins (gag, env) in patients' sera and sequences representing intact HTLV-I proviral genomes in peripheral blood mononuclear cells (PBMC) (2) (3) (4) 7) . Although an association between HTLVs and the cutaneous T cell lymphoma, mycosis fungoides (MF), and its leukemic variant, the Sezary syndrome (SS), has long been suspected, definitive evidence for such a relationship has been difficult to establish. Only 1-10% of MF patients, who live in HTLV nonendemic areas, have detectable antibodies to HTLV-I/II (8) (9) (10) (11) (12) , and HTLV-related proviral sequences are usually not detected in their PBMC by Southern analysis alone. Other observations, which have put the relatedness of ATLL and MF in question, concern the nature of the neoplastic cell itself. Although both the ATLL and MF/SS cells are CD4+ helper T lymphocytes (13, 14) , MF or Sezary cells, terms used interchangeably here, usually lack receptors for IL-2 (15) and fail to proliferate spontaneously, in vitro ( 13, 15, 16) . Their cerebriform nucleus is distinct from the "flower nucleus" of ATLL cells (14, (17) (18) (19) (20) . Rearrangements of the T cell receptor /6 chain are not consistently demonstrable (21) . Although karyotypic abnormalities have been observed in some cases (22) (23) (24) , no disease-specific chromosomal alterations have been identified. It was not until hematopoietic growth factors became available that attempts to culture Sezary cells became feasible (16) . This led to the discovery that PBMC from almost all patients with MF become immortalized after a few weeks in culture when growth factors can be withdrawn and that they release particles which, ultrastructurally, are indistinguishable from HTLV-I (16) . In several instances, the identity of these particles as HTLV could be confirmed by immunoelectron microscopy and/or immunohistochemistry (16) and the polymerase chain reaction (PCR), combined with Southern analysis, detected relevant proviral DNA sequences (16, 25) . One patient's PBMC were shown to harbor DNA sequences related to HTLV-ll (25) . On the basis of these tantalizing observations, a more systematic effort was undertaken to prove that MF/SS is also an HTLV-associated disease. Firstly, biomolecular analyses were carried out on freshly isolated blood specimens rather than on cultured cells, and, secondly, a major effort was focused on the detection of tax, the putative HTLV-transforming gene (4, (26) (27) (28) (29) (30) which, so far, has not been found among human endogenous retroviral or other human genomic sequences (4, (31) (32) (33) . We are now able to report that most, if not all, MF patients possess proviral DNA sequences related to HTLV tax and/or pol-I in their circulating mononuclear cells. Iranian   SCCO   70   59   20  46  60  31   45   30  43   53   38  18  42  nd  26   65   19  34  27  72  78  16  33  40  61  94  21  71  25  30  22   56  25  18  52  20  47  27  29  27  27  26  29  43  29  58   47  60  25 Southern blot hybridization. PCR products were resolved through 4% agarose gels in the presence of ethidium bromide in TAE (0.04 M Tris-acetate, 0.001 M EDTA) buffer as described previously (16, 25 ). DNAs in gels were then denatured in 1.5 M NaCl, 0.5 M NaOH, neutralized in 3 M Na acetate, pH 5.5, followed by overnight transfer to Biotrans nylon membranes (ICN Biomedicals Inc., Irvine, CA) by the method of Southern (43) . Prehybridization, hybridization, and posthybridization washes were conducted essentially as described previously (16, 25) , with the following exceptions. Prehybridization and hybridization were performed for 2 h and overnight, respectively, at 43°(. Probes SKI 12 (HTLV-I pol) and SK45 (for HTLV I/II tax) ( Fig. 1) were 3'-tailed with digoxigenin-l1-dUTP, using reagents and procedures from the Genius 6 nonradioactive probe labeling kit (Boehringer Mannheim Biochemicals, Indianapolis, IN) (44) . Hybridization to detect HTLV tax was performed in the presence of 50% formamide. After hybridization, filters were subjected to 2-15-min washes in 2 x SSC, 0.1 % SDS and, 2-15-min washes in 0.2 X SSC, 0.1% SDS, all at room temperature, followed by a wash at 550( in 0.2 x SSC, 0.1% SDS.
Bound probe was detected using reagents and procedures included in the Genius 3 kit (Boehringer Mannheim Biochemicals). Filters were blocked and further incubated in the presence of Fab' fragments of antibodies to digoxigenin that were conjugated with alkaline phosphatase and then in the substrates 4-nitroblue tetrazolium and 5-bromo-4-chloro-3-indolyl-phosphate (44) . HTLV-positive and -negative cell samples were included in all experiments.
Cloning and sequencing ofHTLV tax PCR products. The full length 159-bp tax PCR products amplified from PBMC of patient F. M. were eluted from 1% agarose gels, phosphorylated by T4 polynucleotide kinase, and blunt-end ligated to SmaI-cleaved pUC19 (45). Recombinant plasmid DNA was introduced into Escherichia coli strain DHFa by electroporation. After amplification in the presence of carbenicillin, colonies harboring plasmids containing HTLV tax-related sequences were identified by colony hybridization, using digoxigenin-tailed SK45. (See the previous section on Southern analysis for details of probe labeling, hybridization, posthybridization filter washing, and detection of bound probe.) Nitrocellulose rather than nylon filters were used for colony hybridization. After alkaline denaturation in 1.5 M NaCl, 0.5 M NaOH, filters were neutralized in 1.5 M NaCl, 0.5 M Tris, pH 7.5, and baked in a vacuum oven at 800C for I h. Plasmid DNAs were selectively isolated using the Promega Corp. (Madison, WI) Magic MiniPreps system. DNAs shown to undergo release of -200-bp fragments (159-bp tax insert + -43-bp pUCl9 vector sequences) that hybridized to HTLV tax, after double digestion with EcoRI and PstI and electrophoresis through 1% agarose gels containing ethidium bromide, were sequenced by the dideoxy chain termination single strand DNA sequencing method of Sanger (46) , using the Sequenase kit reagents and procedures obtained from the U. S. Biochemical Corp. (Cleveland, OH). Reactions were labeled by incorporation of 35S-dATP, and chain-terminated reaction products were electrophoresed through 6% polyacrylamide sequencing gels. Sequences were determined after autoradiography of dried gels and were compared with those published for prototypic HTLV-I and -II tax sequences (31, 37, 47, 48) . PCR products from PBMC of patients R. A. and R. B., in addition to those from the HTLV-I-infected cell line C91PL, were cloned directly, using the pGEM-T vector system (Promega Corp.) and sequenced by Dr 
Results
Detection of HTLV-like virus particles in cultures of PBMC from MF patients. Particles indistinguishable from HTLV-I were detected by electron microscopy in cultures of PBMC of all patients presented in this report (Fig. 2) . Such particles have never been observed in lymphocyte cultures from healthy individuals.
Detection of HTLV proviral sequences by PCR/Southern analysis. Fig. 3 shows the results of representative Southern blots of pol-I and tax sequences amplified from PBMC of 10 MF patients of the 50 tested. As seen in Fig. 3 A, when PCRamplified DNAs were subjected to Southern analysis, the pol-1 probe hybridized to DNA amplified from PBMC from nine of these patients, as it did to DNA from the prototypic HTLV-I cell line, C9lPL. No pol-related bands were detected in samples from the HTLV-ll cell line, MoT, the healthy control, or in the sample obtained from patient M. M.
The tax probe bound to DNA amplified from both the prototypic HTLV-I and HTLV-ll cell lines (I and II in Fig. 3 B) and to PBMC-derived DNA amplified from all 10 MF patients. Nucleotide sequence determination of the amplified tax region. The cloned nucleotide sequences of the HTLV tax region amplified and detected in the PBMC from three of these patients, R. A., R. B., and F. M., are compared with those published for the prototypic HTLV-I-infected cell line MT-2 (31, 48) , as shown in Fig. 4 . Only four nucleotide base pair differences were detected in this region between HTLV-I and the patients' amplified sequences. Of these, one G to A transition observed for patient F. M. only would be predicted to result in an arginine (CGC) to histidine (CAC) exchange and the other (T to C) (patients R. B. and F. M.) in replacement of isoleucine (ATC) with threonine (ACC). The double base pair change (CT to TC), observed in all three MF patients, would not be (25) in PBMC cultures of practically all patients with the cutaneous T cell lymphoma, MF, and its leukemic variant, the Sezary syndrome. Such reasons can be offered. First of all, patients with MF are usually seronegative for antibodies to the virus, discouraging further analysis in a clinical setting, especially since antibody positivity can usually be relied on in the diagnosis of HTLV-associated ATLL. Furthermore, patients with the endemic form of ATLL usually harbor proviral sequences spanning the entire HTLV-I genome. As a rule, their PBMC possess sufficient levels of proviral DNA to be detected by standard Southern blot hybridization techniques. This proved to be futile in the case of mycosis fungoides. It has taken the development of the PCR and the use of a variety of primers and probes to uncover evidence of HTLV infection in the majority of MF patients. It is not clear why our efforts were more successful than those of others ( 11, (52) (53) (54) in showing a high incidence of HTLV in MF patients, many of whom are Caucasian and do not originate from HTLV-I-endemic areas (see Table I ). Part of the reason for the inconsistent detection of HTLV sequences is likely to be due to the low levels of virus or to the presence of incomplete or variant proviral sequences in the samples studied. It is too early to tell whether patients who have been shown to harbor tax but not pol-I sequences, or those who have pol but no tax sequences, actually have defective viruses, or whether variant HTLV sequences not amplified or detected by the primers/probes used, so far, are responsible for these results. On the other hand, only one of the patients, reported in more detail elsewhere (25) has been shown to be infected with HTLV-II. Use of pol-il-specific primers/probes has not resulted in detection of homologous sequences in the cells of any of the other patients studied (data not shown). Although the tax primers and probe used did not distinguish HTLV-I from HTLV-II, the sequence analysis of DNA amplified from three of the patients (Fig. 4) resembles HTLV-I in the region of tax examined (31, 37, 47, 48) . HTLV-I and -II differ in this region by 25 bp (48) . The significance of finding the same TC-CT base pair change in all three patients has yet to be established in that no predicted amino acid change would be expected. However, the observations that the patients do each differ from each other and from the prototypic HTLV-I sequence in the region of tax studied, albeit by only a few base pairs, essentially rule out the possibility that the viral sequences detected are contaminants. Multiple clones derived from DNA from PBMC of patients F. M. and R. B. were used to exclude artifactual PCR sequences. Therefore, the data suggest that MF is more likely to be associated with HTLV-I.
Despite the finding that peripheral blood cells of > 90% of MF patients possess HTLV-related proviral sequences, only three patients had antibodies to HTLV-I/II structural proteins (see Table I ). The antibody-negative status of most of the MF patients warrants comment. It is possible that MF patients carry incomplete or variant proviral genomes as has been suggested by others (10, 11, 55) . However, it is not generally appreciated that even patients with ATLL, living in endemic areas, may lack antibodies to the virus (56) , and their PBMC may reveal only defective HTLVs (32, 57, 58) . Where characterized in detail, gene sequences encoding viral structural proteins, such as env and gag, have been found to be missing (32, (57) (58) (59) . Therefore, it is conceivable that MF patients fail to mount an immune response to HTLV structural proteins simply because the relevant viral gene products are no longer made. Alternatively, these patients may be infected with a virus sufficiently different in gag and env from those of the HTLV-I or -II prototypes, such that their antibodies would escape detection in standard serological tests using prototypic HTLV antigens. It is also possible that, in some cases, such particles may result from activation of endogenous retroviral gag sequences known to exist in the human genome (60) . Lastly, the patients may have a selective type of immunosuppression which remains to be defined.
In any event, the salient observation communicated here is that proviral HTLV sequences have been detected in the vast majority of patients with MF. Since tax has never been reported among endogenous human retroviruses, this observation is probably significant. At the very least, the presence of pX region sequences in such patients is of interest because of the demonstrated role of tax, one of the gene products from this region, in neoplastic transformation (26, 28, 29, 61, 62) . HTLV 
